Forest Labs goes after Icahn's board nominees; Seattle Genetics chief says 'no sale';

 @FiercePharma: Hide the keys, Ambien users: Sanofi sleep aid linked to another high-profile driving mishap. Item | Follow @FiercePharma

> In its latest missive to shareholders, Forest Laboratories ($FRX) criticized Carl Icahn's nominees for its board, saying they have "significant and obvious conflicts." Report

> Seattle Genetics ($SGEN) CEO Clay Siegall says he has no intention of selling the company; he prefers to build up sales of the cancer drug Adcetris himself. Report

> South Africa's Adcock Ingram agreed to buy the Indian drugmaker Cosme Pharma for access to the fast-growing drug market on the subcontinent. Report

> The Alabama Supreme Court tossed a $78.4 milion verdict against Novartis' ($NVS) generics unit Sandoz, in a case alleging that the company defrauded the state's Medicaid program. Report

> Questor defended its Acthar drug as shares plummeted on a short seller's report questionin the company's marketing abilities. Report

> India's Aurobindo Pharma said it would challenge a local pollution board's order that it shut down a manufacturing facility in Andhra Pradesh. Report

Biotech News

 @FierceBiotech: Quintiles, Allscripts to tap health ‪IT‬ data for drug research. Item | Follow @FierceBiotech

 @JohnCFierce: Ugh, venture investors rank biotech among the basement dwellers in terms of tech confidence. More | Follow @JohnCFierce

 @RyanMFierce: Diabetes care goes Big Data. Sanofi has awarded n4a Diabetes Care $100K to advance ‪Big Data analysis. Release | Follow @RyanMFierce

> Juventas snags $22M B round for mid-stage stem cell program. News

> Who's next on Big Pharma's biotech shopping list? More

> GSK closes the deal on Human Genome Sciences for $3B. News

> Diagnostic deals surge as developers target more new drugs. Item

Medical Device News

@FierceMedDev: The FDA is investigating how 75,000 pages of confidential, device-related docs got leaked online. Report | Follow @FierceMedDev

@MarkHFierce: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @MarkHFierce

@DamianFierce: St. Jude reports that large-diameter Riata models are more likely to erode than smaller ones. Article | Follow @DamianFierce

> Device tax repeal amendment fails in Senate. Item

> Kinetic Concepts cutting 300 more jobs. Story

> Thermo Fisher snaps up One Lambda for $925M. News

Biotech IT News

> Sanofi pins winner in hunt for digital diabetes breakthroughs. Item

> Stanford rides Big Data wave in medical research. More

> Intel and NextBio seek Big Data upgrades in genomics. Article

> Eli Lilly aims to up social media game. More

And Finally... Congress cried foul on FDA's surveillance of staff scientists who blew the whistle on what they considered shortcomings in the agency's device-review process. Report